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Faciogenital dysplasia (FGDY, MIM*305400), or Aarskog syn- 
drome, is a rare X-linked recessive multisystemic disease of ab- 
normal human embryonic development. The disease phenotype 
consists of a number of facial, skeletal, and urogenital malforma- 
tions. Major manifestations include disproportionate short stature 
and shortened distal extremities (Porteous and Goudie 1991). Ra- 
diographic abnormalities include hypoplastic phalanges, retarded 
bone maturation, and a variety of vertebral anomalies including 
cervical spina bifida occulta, odontoid hypoplasia, and segmenta- 
tion anomalies. Facial features typically consist of hypertelorism, 
external ear anomalies, and maxillary hypoplasia. Scrotal anoma- 
lies, penile hypospadius, and kidney hypoplasia comprise some of 
the observed urogenital malformations (Gorlin et al. 1990). 
Pedigree analyses of families segregating FGDY, and genetic 
linkage studies in some affected families, confirmed that FGDY 
was X-linked and mapped to the pericentric region of the human X 
Chromosome (Chr) (Porteous et al. 1992; Stevenson et al. 1994). 
FGDY was also mapped to this region on the basis of the obser- 
vation of a mother and son who both displayed all of the major 
characteristics of FGDY in association with a reciprocal X;8 chro- 
mosome translocation (Bawle et al. 1984). This FGDY-specific 
translocation breakpoint was mapped by somatic cell and radiation 
hybrid analyses to a 350-kb interval within Xpll.21 that was 
flanked by markers ALAS2 and DXS323 (Gorski et al. 1992; 
Glover et al. 1993). By using a positional cloning strategy, the 
gene responsible for FGDY, termed FGD1, was recently isolated 
and characterized (Pasteris et al. 1994). 
In this study, the mouse FGD1 homolog, Fgdl, was isolated 
and mapped to the mouse X Chr. A human FGD1 cDNA, clone 
pFCF3.85 (Pasteris et al. 1994), which contained the entire open 
reading frame (ORF), was used as a hybridization probe to screen 
a lambda gtl0 library derived from e7.5 mouse embryonic ecto- 
derm. The three mouse cDNA clones with the largest inserts were 
subcloned into Bluescript KSII(+) and sequenced (Pasteris et al. 
1994). To facilitate DNA sequencing, we used oligonucleotides 
directed against the human FGD1 sequence for sequencing; di- 
rected against the mouse cDNAs, 80% of these oligonucleotide 
primers yielded interpretable sequence data. These results sug- 
The nucleotide sequence data reported in this paper have been submitted 
to GenBank and have been assigned the accession number U22325. 
gested that a high degree of nucleotide sequence conservation 
existed between FGD1 cDNA clones derived from human and 
mouse. 
The overlapping mouse cDNA clones corresponded to 3080 bp 
of contiguous nucleotide eDNA sequence and contained a 2880- 
nucleotide ORF predicted to encode a protein of 960 amino acids, 
one amino acid shorter than the human FGD 10RF. Comparison of 
the mouse and human sequences within the coding region indi- 
cated 94.7% identity (96.3% similarity) at the amino acid level 
(Fig. 1A). The nucleotide sequence of all three mouse cDNAs 
terminated at an identical EcoRI site that corresponded to position 
3713 of the human FOD1 and included 97 bp of 3' untranslated 
sequence. In addition, the largest mouse cDNA contained 104 bp 
of 5' untranslated sequence (Fig. 1B). Compared with the human 
FGD1 nucleotide sequence, the 5' untranslated region, the ORF, 
and the 3' untranslated region of the mouse cDNA were 95%, 92%, 
and 75% identical respectively. The predicted translation initiation 
sites of both the human and mouse cDNAs were identical. To- 
gether, these results strongly suggested that the composite mouse 
eDNA represented the mouse homolog of the human FGD1 gene, 
which was designated Fgdl. 
An analysis of the derived Fgdl and FGD1 protein sequences 
predicted proteins with Rho/Rac guanine nucleotide exchange fac- 
tor (OEF) activity. Rho/RacGEFs form a family of cytoplasmic 
proteins that activate the Ras-like family of Rho and Rac proteins 
by facilitating the exchange of bound ODP for free OTP (Boguski 
and McCormick 1993). The Fgdl GEF domain (180 residues from 
aa 375-559) was virtually identical (99.5% identity) to the Rho/ 
RacGEF domain of the human FGDI sequence (Fig. 1A). In ad- 
dition, a comparison of the predicted mouse and human FGD1 
protein sequences determined that both genes encoded the same 
putative structural motifs (Fig. 1B). These included a zinc-finger- 
like structural motif that was similar to but distinct from the zinc- 
finger regulatory domain of protein kinase C, a pleckstrin homol- 
ogy domain, and a proline-rich amino terminus domain that con- 
tained potential Src-homology 3 (SH3) binding sites (Pasteris et al. 
1994). Another potential functional motif, an acidic peptide seg- 
ment directly upstream from the GEF domain, was identified in the 
human/mouse comparison. A stretch of ten glutamic acid residues 
in the mouse gene (aa 339-349) was matched by 11 acidic residues 
in the human FGD1 polypeptide (EEEDDEEEEEE). Other Rho/ 
RacGEFs also contained acidic stretches upstream of the GEF 
domain; for example, rasGRF contained stretches of EDGEVEIE 
and EDEDSD residues in a similar region (GenBank accession No. 
P28818). 
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Fig. 1. Comparisons of the mouse and huma~ predicted Fgdl protein 
sequences. (A) The predicted mouse (top) and human (bottom) Fgdl pro- 
tein sequences were aligned by use of the BESTFIT program of the GCG 
software package (Devereux et al. 1984); vertical lines between amino 
acids indicate identity, double dots signify conserved amino acids. The 
mouse Fgdl sequences and the human FGD1 sequences are deposited in 
GenBank under accession numbers U22325 and U11690 respectively. A 
schematic representation of the Fgd] sequence is shown below (B). The 
ORF region is shown as a boxed segment. Identified structural domains are 
indicated and include (left to right): a proline-rich N-terminus containing 
putative Src-homology 3 (SH3) binding sites, a Rho/Rac guanine nucle- 
otide exchange factor (GEF) domain, a pleckstfin homology (PH) domain, 
and a cysteine-rich, zinc-finger-like domain. 
In order to further confirm that Fgdl was indeed the mouse 
homolog of FGD1, we determined the mouse chromosomal loca- 
tion of Fgdl. An interspecific backcross analysis was carried out 
with progeny derived from matings of (B6CBA-AW4/A-Bpa) x 
Mus spretus mice, as previously described by Herman and Walton 
(1990). This interspecific backcross mapping panel consisted of 
126 animals with recombination events spanning the mouse X Chr, 
including 28 crossovers between Ags and Amg. Rapid regional 
mapping was performed by genotyping 14 mice representing 
crossover events spanning several anchor loci distributed along the 
entire X Chr (data not shown). These data positioned Fgdt be- 
tween the anchor loci Ags and Amg, as expected from comparative 
human and murine maps (Fig. 2 and Table 1). 
For finer resolution for loci mapped to the interval between 
Ags and Amg, mice were also typed for three microsatellites, 
DXMit12, 34, and 35, as well as for cDNA marker Alas2. The 
Alas2 locus had been previously mapped to the interval between 
Ags and Amg by Chapman and associates (1994). The Alas2 and 
Fgdl probes detected a BamHI variation (RFLV) between Mus 
spretus and C57BL/6J, thus providing a means for scoring the 
interspecific backcross. The mapping results favored a gene order 
of: cen-Ags-DXMit35-(Alas2, DXMit34)-Fgdl-DXMit12-Amg- 
tel (Fig. 2, Table 1). As shown in Table 1, a single double recom- 
binant, mouse 199, was detected in these studies and, thus, the 
relative order for DXMitl2 and Amg was based on data from 
independent, multilocus, interspecific backcrosses (Herman et al. 
1994). The Fgdl locus was mapped 0.79 cM (+ a standard error of 
0.79 cM) telomeric to Alas2 and 6.3 cM (+2.2 cM) centromeric to 
DXMitl2. The observation that, like the human FGD1 locus, the 
mouse Fgdl gene was closely linked to Alas2 further confirmed 
that the isolated cDNA clones represented the Fgdl locus. These 
results also extended and confirmed that a cluster of loci within the 
human proximal short arm of the X Chr within region Xpl 1.21 
mapped to the distal region of the mouse X Chr, extending the 
observations of Blair and colleagues (1994). 
Several mouse mutations have been tentatively mapped to the 
distal portion of the mouse X Chr. These include gyro (Gy), hy- 
phosphatemia (Hyp), lined (Li), and X-linked polydactyly (Xpl) 
(Lyon and Seafle, 1989). These mutations are manifested by hy- 
pophosphatemia, rickets, inner ear abnormalities, sterility, and 
polydactyly, features not associated with the FGDY phenotype. 
However, because the reported cases of FGDY have been associ- 
ated with FGD1 null alleles only (Pasteris et al. 1994), and since 
it is not known what phenotype(s) may be associated with more 
subtle FGD1 mutations, it is not possible to absolutely exclude the 
possibility that Fgdl is responsible for one of these mouse muta- 
tions. 
An examination of the nucleotide and deduced protein se- 
quences of Fgdl and FGD1 revealed a high degree of homology 
between the two genes9 The remarkable fidelity of amino acid 
conservation of all structural motifs identified in Fgdl, including 
the Rho/RacGEF domain, may signify that the mouse and human 
signaling cascades are also equally well conserved. Other potential 
components of this pathway, such as the mouse and human Racl ,  
Rac2, and Cdc42 proteins, are 100% conserved at the amino acid 
level (unpublished observation, Pasteris). These results and obser- 
vations strongly suggest that the mouse will serve as a useful 
model for studying and characterizing the Fgdl development sig- 
nal transduction system9 
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Fig. 2. Genetic mapping Fgdl in an interspecific backcross. (A) Analysis  
of 126 animals at Ags, DXMit35, Alas2, DXMit34, Fgdl, DXMitl2, and 
Amg. All 126 N 2 progeny were typed for the loci Ags, DxMitl2, and Amg. 
Only the 28 recombinant  progeny were typed for the additional loci  
DXMit35, Alas2, DXMit34, and Fgdl. Black boxes represent Mus spretus 
alleles, and white boxes represent B6CBA-AW4/A-Bpa(domesticus) alMes. 
A schematic representation of the mouse X Chr is shown to the right of the 
Table I. Haplotype analysis of X Chromosome markers) 
Alas2. 
Mouse A g e s  DXMir35 DXMIT34 Fgdl DXMit]2 Amg 
102 S x B B B B B 
119 S x B B B B B 
124 S x B B B B B 
147 S x B B B B B 
220 S x B B B B B 
233 S x B B B B B 
235 S x B B B B B 
247 S x B B B B B 
253 S x B B B B B 
268 S x B B B B B 
161 B x S S S S S 
216 B x S S S S S 
243 B x S S S S S 
278 B x S S S S S 
280 B x S S S S S 
199 S S x B B B x S 
160 B B x S S S S 
210 B B x S S S S 
274 B B B x S S S 
42 S S S S x B B 
20I S S S S x B B 
202 S S S S x B B 
204 S S S S x B B 
266 S S S S x B B 
217 B B B B x S S 
229 B B B B x S S 
276 B B B B x S S 
209 S S S S S x B 
a S denotes Mus spretus allele; B denotes B6CBA-A =/A-Bpa allele; • indicates a 
recombination event. 
figure (B). The order and position of the anchor loci were previously 
described (Herman et al. 1994). Calculated distances between markers are 
shown to the right of the figure. PCR primers for DXMitl2, 34 and 35 were 
purchased from Research Genetics and used as recommended by the mau- 
ufacturer. Genomic DNA restriction digests, electrophoresis, and Southern 
blotting to Sure Blot membranes (Oncor) were performed as described 
(Herman and Walton 1990; Angel  et al. 1993). 
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